Ye Xiaoping

CEO, Hangzhou Tigermed Consulting

Real-Time Net Worth

$1.5B

As of December 2025

Age

Source

Pharmaceuticals

Industry

healthcare

Citizenship

Biography

Ye Xiaoping, at 62 years old, is a prominent figure in China's pharmaceutical industry, serving as the Chairman of Hangzhou Tigermed Consulting. His estimated net worth is $1.5 billion, a testament to his success in the healthcare sector. Ye's career includes executive roles at Roche, a Swiss pharmaceutical giant, before becoming an entrepreneur. Tigermed, founded in 2004, has grown to become one of China's largest contract research organizations. Ye's achievements are underscored by his EMBA from Peking University and a Ph.D. from Oxford University, highlighting his commitment to both business and education. His wealth is primarily derived from his pharmaceutical ventures, showcasing his influence in the rapidly expanding Chinese healthcare market.

Wealth Over Time

In-Depth Profile

Early Life and Education

Ye Xiaoping was born in China and pursued higher education, earning an EMBA from Peking University and a Ph.D. from Oxford University. His academic achievements laid a strong foundation for his future career in the pharmaceutical industry.

Career and Rise to Success

Before becoming an entrepreneur, Ye Xiaoping held an executive position at Roche, a prominent Swiss pharmaceutical company. This experience provided him with valuable insights and expertise in the industry. In 2004, he founded Hangzhou Tigermed Consulting, a contract research organization (CRO) in the pharmaceutical sector. Under his leadership, Tigermed has grown to become one of China's largest CROs, offering clinical research services and contributing significantly to the development of the pharmaceutical industry.

Key Business Strategies

Ye Xiaoping's success is attributed to several key business strategies. He focused on providing comprehensive clinical research services, including clinical trial technology, data management, and statistical analysis. Tigermed has established a presence in multiple countries with numerous subsidiaries, demonstrating a strong focus on expansion and globalization. His leadership also involves innovation and a commitment to excellence, which has driven the company's growth and reputation.

Philanthropy

Information regarding Ye Xiaoping's specific philanthropic activities and amounts are currently unavailable based on the search results.

Career Milestones

2004

Founded Tigermed

Established Hangzhou Tigermed Consulting, a contract research organization, which became one of China's largest in the industry.

Prior to 2004

Executive at Roche

Worked as an executive at the Swiss pharmaceutical giant Roche, gaining experience in the industry.

2023

Chairman of Hangzhou Tigermed Consulting

Appointed as the Chairman of Hangzhou Tigermed Consulting.

Philanthropy & Social Impact

Unknown

Undisclosed

Specific philanthropy details are not available.